The Low Rate of Adherence to Checklist for Artificial Intelligence in Medical Imaging Criteria Among Published Prostate MRI Artificial Intelligence Algorithms

被引:13
|
作者
Belue, Mason J. [1 ]
Harmon, Stephanie A. [1 ]
Lay, Nathan S. [1 ]
Daryanani, Asha [1 ]
Phelps, Tim E. [1 ]
Choyke, Peter L. [1 ]
Turkbey, Baris [1 ,2 ]
机构
[1] NCI, Artificial Intelligence Resource, Mol Imaging Branch, NIH, Bethesda, MD USA
[2] NCI, Artificial Intelligence Resource, Mol Imaging Branch, 10 Ctr Dr,MSC 1182,Bldg 10,Room B3B85, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
AI; CLAIM; classi fi cation; detection; prostate cancer; study rigor; CANCER DETECTION; CLINICALLY SIGNIFICANT; GLEASON SCORE; RADIOMICS; CLASSIFICATION; VALIDATION; DIAGNOSIS; FEATURES; IMAGES;
D O I
10.1016/j.jacr.2022.05.022
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: To determine the rigor, generalizability, and reproducibility of published classification and detection artificial intelligence (AI) models for prostate cancer (PCa) on MRI using the Checklist for Artificial Intelligence in Medical Imaging (CLAIM) guidelines, a 42-item checklist that is considered a measure of best practice for presenting and reviewing medical imaging AI research.Materials and methods: This review searched English literature for studies proposing PCa AI detection and classification models on MRI. Each study was evaluated with the CLAIM checklist. The additional outcomes for which data were sought included measures of AI model performance (eg, area under the curve [AUC], sensitivity, specificity, free-response operating characteristic curves), training and validation and testing group sample size, AI approach, detection versus classification AI, public data set utilization, MRI sequences used, and definition of gold standard for ground truth. The percentage of CLAIM checklist fulfillment was used to stratify studies into quartiles. Wilcoxon's rank-sum test was used for pair-wise comparisons.Results: In all, 75 studies were identified, and 53 studies qualified for analysis. The original CLAIM items that most studies did not fulfill includes item 12 (77% no): de-identification methods; item 13 (68% no): handling missing data; item 15 (47% no): rationale for choosing ground truth reference standard; item 18 (55% no): measurements of inter-and intrareader variability; item 31 (60% no): inclusion of validated interpretability maps; item 37 (92% no): inclusion of failure analysis to elucidate AI model weaknesses. An AUC score versus percentage CLAIM fulfillment quartile revealed a significant difference of the mean AUC scores between quartile 1 versus quartile 2 (0.78 versus 0.86, P = .034) and quartile 1 versus quartile 4 (0.78 versus 0.89, P = .003) scores. Based on additional information and outcome metrics gathered in this study, additional measures of best practice are defined. These new items include disclosure of public dataset usage, ground truth definition in comparison to other referenced works in the defined task, and sample size power calculation.Conclusion: A large proportion of AI studies do not fulfill key items in CLAIM guidelines within their methods and results sections. The percentage of CLAIM checklist fulfillment is weakly associated with improved AI model performance. Additions or supplementations to CLAIM are recommended to improve publishing standards and aid reviewers in determining study rigor.
引用
收藏
页码:134 / 145
页数:12
相关论文
共 50 条
  • [1] Artificial intelligence in medical imaging of the liver
    Zhou, Li-Qiang
    Wang, Jia-Yu
    Yu, Song-Yuan
    Wu, Ge-Ge
    Wei, Qi
    Deng, You-Bin
    Wu, Xing-Long
    Cui, Xin-Wu
    Dietrich, Christoph F.
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (06) : 672 - 682
  • [2] Artificial Intelligence in Medical Imaging of the Breast
    Lei, Yu-Meng
    Yin, Miao
    Yu, Mei-Hui
    Yu, Jing
    Zeng, Shu-E
    Lv, Wen-Zhi
    Li, Jun
    Ye, Hua-Rong
    Cui, Xin-Wu
    Dietrich, Christoph F.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Artificial Intelligence in Medical Imaging
    Wagner, Jessyca B.
    RADIOLOGIC TECHNOLOGY, 2019, 90 (05) : 489 - 501
  • [4] Evaluating artificial intelligence for medical imaging: a primer for clinicians
    Keni, Shivank
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2024, 85 (07)
  • [5] Radiomics and artificial intelligence in prostate cancer: new tools for molecular hybrid imaging and theragnostics
    Liberini, Virginia
    Laudicella, Riccardo
    Balma, Michele
    Nicolotti, Daniele G.
    Buschiazzo, Ambra
    Grimaldi, Serena
    Lorenzon, Leda
    Bianchi, Andrea
    Peano, Simona
    Bartolotta, Tommaso Vincenzo
    Farsad, Mohsen
    Baldari, Sergio
    Burger, Irene A.
    Huellner, Martin W.
    Papaleo, Alberto
    Deandreis, Desiree
    EUROPEAN RADIOLOGY EXPERIMENTAL, 2022, 6 (01)
  • [6] Artificial intelligence development for detecting prostate cancer in MRI
    Aphinives, Chalida
    Aphinives, Potchavit
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2021, 52 (01)
  • [7] WFUMB Commentary Paper on Artificial intelligence in Medical Ultrasound Imaging
    Cui, Xin Wu
    Goudie, Adrian
    Blaivas, Michael
    Chai, Young Jun
    Chammas, Maria Cristina
    Dong, Yi
    Stewart, Jonathon
    Jiang, Tian-An
    Liang, Ping
    Sehgal, Chandra M.
    Wu, Xing-Long
    Hsieh, Peter Ching-Chang
    Adrian, Saftoiu
    Dietrich, Christoph F.
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2025, 51 (03) : 428 - 438
  • [8] Artificial intelligence and medical imaging
    Sun, Roger
    Deutsch, Eric
    Fournier, Laure
    BULLETIN DU CANCER, 2022, 109 (01) : 83 - 88
  • [9] Tasks for artificial intelligence in prostate MRI
    Belue, Mason J.
    Turkbey, Baris
    EUROPEAN RADIOLOGY EXPERIMENTAL, 2022, 6 (01)
  • [10] Artificial intelligence and radiomics in MRI-based prostate diagnostics
    Hamm, Charlie Alexander
    Beetz, Nick Lasse
    Savic, Lynn Jeanette
    Penzkofer, Tobias
    RADIOLOGE, 2020, 60 (01): : 48 - 55